Title : Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells.

Pub. Date : 2015 Jul

PMID : 26171069






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 It was observed that combined administration of cisplatin and bortezomib induced upregulation of caspase-3, -8 and -9, B-cell lymphoma-2 (Bcl-2)-like 11 and Bcl-2-interacting killer, but downregulated Bcl-2 and Bcl-extra large protein expression levels in T24 cells in a dose-dependent manner. Cisplatin BCL2 apoptosis regulator Homo sapiens
2 It was observed that combined administration of cisplatin and bortezomib induced upregulation of caspase-3, -8 and -9, B-cell lymphoma-2 (Bcl-2)-like 11 and Bcl-2-interacting killer, but downregulated Bcl-2 and Bcl-extra large protein expression levels in T24 cells in a dose-dependent manner. Cisplatin BCL2 apoptosis regulator Homo sapiens
3 It was observed that combined administration of cisplatin and bortezomib induced upregulation of caspase-3, -8 and -9, B-cell lymphoma-2 (Bcl-2)-like 11 and Bcl-2-interacting killer, but downregulated Bcl-2 and Bcl-extra large protein expression levels in T24 cells in a dose-dependent manner. Cisplatin BCL2 apoptosis regulator Homo sapiens